Piperidine, 1-(2-naphthalenylmethyl)- → HCID 21393757, 화합물

반응식

[N:1]1([CH2:7][C:8]2[CH:17]=[CH:16][C:15]3[C:10](=[CH:11][CH:12]=[CH:13][CH:14]=3)[CH:9]=2)[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.[Cl:18][CH2:19][N:20]1[CH2:25][CH2:24][O:23][CH2:22][CH2:21]1>>[ClH:18].[ClH:18].[O:23]1[CH2:24][CH2:25][N:20]([CH2:19][C:9]2[C:10]3[C:15](=[CH:14][CH:13]=[CH:12][CH:11]=3)[CH:16]=[CH:17][C:8]=2[CH2:7][N:1]2[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6]2)[CH2:21][CH2:22]1

참가 물질

반응물 2

HCID 204543Piperidine, 1-(2-naphthalenylmethyl)-

HCID 123310834-(Chloromethyl)morpholine

생성물 1

HCID 21393757HCID 21393757, 화합물

실험 절차

1-Morpholinomethyl-2-piperidinomethylnaphthalene dihydrochloride, m.p. 243°-244° was prepared in a manner similar to Example 40 from 2-piperidinomethylnaphthalene and chloromethylmorpholine.

출처 및 근거

ORD 기록: ord-5ec510afc75f4f91bd0aab13a840347e
출처 데이터셋: uspto-grants-1977_12
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US04062955

반응 노트

불러오는 중…